| Title |
Utilization of COVID-19 Treatments and Clinical Outcomes among Patients with Cancer: A COVID-19 and Cancer Consortium (CCC19) Cohort Study
|
|---|---|
| Published in |
Cancer Discovery, October 2020
|
| DOI | 10.1158/2159-8290.cd-20-0941 |
| Pubmed ID | |
| Authors |
Donna R. Rivera, Solange Peters, Orestis A. Panagiotou, Dimpy P. Shah, Nicole M. Kuderer, Chih-Yuan Hsu, Samuel M. Rubinstein, Brendan J. Lee, Toni K. Choueiri, Gilberto de Lima Lopes, Petros Grivas, Corrie A. Painter, Brian I. Rini, Michael A. Thompson, Jonathan Arcobello, Ziad Bakouny, Deborah B. Doroshow, Pamela C. Egan, Dimitrios Farmakiotis, Leslie A. Fecher, Christopher R. Friese, Matthew D. Galsky, Sanjay Goel, Shilpa Gupta, Thorvardur R. Halfdanarson, Balazs Halmos, Jessica E. Hawley, Ali Raza Khaki, Christopher A. Lemmon, Sanjay Mishra, Adam J. Olszewski, Nathan A. Pennell, Matthew M. Puc, Sanjay G. Revankar, Lidia Schapira, Andrew Schmidt, Gary K. Schwartz, Sumit A. Shah, Julie T. Wu, Zhuoer Xie, Albert C. Yeh, Huili Zhu, Yu Shyr, Gary H. Lyman, Jeremy L. Warner |
X Demographics
The data shown below were collected from the profiles of 195 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 96 | 49% |
| United Kingdom | 6 | 3% |
| France | 4 | 2% |
| Mexico | 4 | 2% |
| Spain | 4 | 2% |
| India | 4 | 2% |
| Australia | 2 | 1% |
| Canada | 2 | 1% |
| Italy | 2 | 1% |
| Other | 19 | 10% |
| Unknown | 52 | 27% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 104 | 53% |
| Scientists | 56 | 29% |
| Practitioners (doctors, other healthcare professionals) | 22 | 11% |
| Science communicators (journalists, bloggers, editors) | 13 | 7% |
Mendeley readers
The data shown below were compiled from readership statistics for 298 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 298 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Researcher | 32 | 11% |
| Student > Bachelor | 28 | 9% |
| Student > Master | 27 | 9% |
| Student > Ph. D. Student | 24 | 8% |
| Other | 21 | 7% |
| Other | 52 | 17% |
| Unknown | 114 | 38% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 75 | 25% |
| Nursing and Health Professions | 21 | 7% |
| Biochemistry, Genetics and Molecular Biology | 8 | 3% |
| Psychology | 7 | 2% |
| Social Sciences | 6 | 2% |
| Other | 45 | 15% |
| Unknown | 136 | 46% |
Attention Score in Context
This research output has an Altmetric Attention Score of 298. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 01 May 2024.
All research outputs
#120,134
of 25,984,008 outputs
Outputs from Cancer Discovery
#45
of 4,182 outputs
Outputs of similar age
#3,644
of 435,725 outputs
Outputs of similar age from Cancer Discovery
#2
of 82 outputs
Altmetric has tracked 25,984,008 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 99th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 4,182 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 22.4. This one has done particularly well, scoring higher than 98% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 435,725 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 99% of its contemporaries.
We're also able to compare this research output to 82 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 97% of its contemporaries.